157 related articles for article (PubMed ID: 32912544)
1. Clinical Characteristics and Analysis of Lung Cancer- Associated Acute Ischemic Stroke.
Zhang J; Zhao J
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105164. PubMed ID: 32912544
[TBL] [Abstract][Full Text] [Related]
2. The Potential Value of D-Dimer to Fibrinogen Ratio in Diagnosis of Acute Ischemic Stroke.
Chen X; Li S; Chen W; Xu F; Wang Y; Zou G; Ren B
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104918. PubMed ID: 32430237
[TBL] [Abstract][Full Text] [Related]
3. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.
Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y
Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer.
Ohara S; Suda K; Tomizawa K; Takemoto T; Fujino T; Hamada A; Koga T; Nishino M; Chiba M; Sato K; Shimoji M; Soh J; Mitsudomi T
Surg Today; 2020 Nov; 50(11):1427-1433. PubMed ID: 32409869
[TBL] [Abstract][Full Text] [Related]
5. Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients.
Quan X; Qin Q; Que X; Chen Y; Wei Y; Chen H; Li Q; Meng C; Liang Z
Clin Appl Thromb Hemost; 2020; 26():1076029620975502. PubMed ID: 33232174
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors, Biomarkers, Etiology, Outcome and Prognosis of Ischemic Stroke in Cancer Patients.
Sorgun MH; Kuzu M; Ozer IS; Yilmaz V; Ulukan C; Cotur Levent H; Tezcan S; Rzayev S; Rawandi A; Bakırarar B; Isikay CT
Asian Pac J Cancer Prev; 2018 Mar; 19(3):649-653. PubMed ID: 29580034
[TBL] [Abstract][Full Text] [Related]
7. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
[TBL] [Abstract][Full Text] [Related]
8. When to Screen Ischaemic Stroke Patients for Cancer.
Selvik HA; Bjerkreim AT; Thomassen L; Waje-Andreassen U; Naess H; Kvistad CE
Cerebrovasc Dis; 2018; 45(1-2):42-47. PubMed ID: 29402826
[TBL] [Abstract][Full Text] [Related]
9. The relationship between plasma D-dimer levels and outcome of Chinese acute ischemic stroke patients in different stroke subtypes.
Yuan W; Shi ZH
J Neural Transm (Vienna); 2014 Apr; 121(4):409-13. PubMed ID: 24201836
[TBL] [Abstract][Full Text] [Related]
10. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
[TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
[TBL] [Abstract][Full Text] [Related]
12. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology.
Schwarzbach CJ; Schaefer A; Ebert A; Held V; Bolognese M; Kablau M; Hennerici MG; Fatar M
Stroke; 2012 Nov; 43(11):3029-34. PubMed ID: 22996958
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Imaging Characteristics of Malignant Tumor Concurrent with Stroke.
Wang F; Hu XY; Cui ZM; Fang XM; Dai Z; Wang T; Guo DL
Cancer Biother Radiopharm; 2019 Oct; 34(8):504-510. PubMed ID: 31295003
[No Abstract] [Full Text] [Related]
14. Hematological Abnormalities and Malnutrition Mediate Pathway between Cancer and Outcomes in Ischemic Stroke Patients.
Gon Y; Kabata D; Kawano T; Kanki H; Todo K; Sasaki T; Shintani A; Mochizuki H
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104943. PubMed ID: 32689614
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke.
Bernard TJ; Fenton LZ; Apkon SD; Boada R; Wilkening GN; Wilkinson CC; Soep JB; Miyamoto SD; Tripputi M; Armstrong-Wells J; Benke TA; Manco-Johnson MJ; Goldenberg NA
J Pediatr; 2010 Apr; 156(4):651-6. PubMed ID: 20022340
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis.
Yamakawa M; Kuno T; Mikami T; Takagi H; Gronseth G
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105288. PubMed ID: 32992199
[TBL] [Abstract][Full Text] [Related]
17. [A clinical study on the pathogenesis of lung cancer-related cerebral infarction].
Xie XR; Qin C; Chen L; Cheng DB; Huang JY; Wei XX; Yu LX; Liang ZJ
Zhonghua Nei Ke Za Zhi; 2017 Feb; 56(2):99-103. PubMed ID: 28162178
[No Abstract] [Full Text] [Related]
18. Cancer-Associated Stroke: The Bergen NORSTROKE Study.
Selvik HA; Thomassen L; Bjerkreim AT; Næss H
Cerebrovasc Dis Extra; 2015; 5(3):107-13. PubMed ID: 26648966
[TBL] [Abstract][Full Text] [Related]
19. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Hypercoagulation Increases the Risk of Early Recurrent Stroke in Patients with Active Cancer.
Fujinami J; Ohara T; Kitani-Morii F; Tomii Y; Makita N; Yamada T; Kasai T; Nagakane Y; Nakagawa M; Mizuno T
Cerebrovasc Dis; 2018; 46(1-2):46-51. PubMed ID: 30064137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
